123 related articles for article (PubMed ID: 22989761)
1. Sca-1 is an early-response target of histone deacetylase inhibitors and marks hematopoietic cells with enhanced function.
Walasek MA; Bystrykh LV; Olthof S; de Haan G; van Os R
Exp Hematol; 2013 Jan; 41(1):113-23.e2. PubMed ID: 22989761
[TBL] [Abstract][Full Text] [Related]
2. Roles of Sca-1 in hematopoietic stem/progenitor cell function.
Bradfute SB; Graubert TA; Goodell MA
Exp Hematol; 2005 Jul; 33(7):836-43. PubMed ID: 15963860
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum-free conditions.
Seet LF; Teng E; Lai YS; Laning J; Kraus M; Wnendt S; Merchav S; Chan SL
Eur J Haematol; 2009 Feb; 82(2):124-32. PubMed ID: 19067743
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid affects the engraftment of TPO-expanded cord blood cells in NOD/SCID mice.
Vulcano F; Milazzo L; Ciccarelli C; Barca A; Agostini F; Altieri I; Macioce G; Di Virgilio A; Screnci M; De Felice L; Giampaolo A; Hassan HJ
Exp Cell Res; 2012 Feb; 318(4):400-7. PubMed ID: 22166516
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression.
Zini R; Norfo R; Ferrari F; Bianchi E; Salati S; Pennucci V; Sacchi G; Carboni C; Ceccherelli GB; Tagliafico E; Ferrari S; Manfredini R;
Exp Hematol; 2012 Dec; 40(12):1043-1054.e6. PubMed ID: 22885124
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of alpha2 integrin separates long-term and short-term reconstituting Lin-/loThy1.1(lo)c-kit+ Sca-1+ hematopoietic stem cells.
Wagers AJ; Weissman IL
Stem Cells; 2006 Apr; 24(4):1087-94. PubMed ID: 16373693
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
[TBL] [Abstract][Full Text] [Related]
9. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P
Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388
[TBL] [Abstract][Full Text] [Related]
10. Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro.
Kircher B; Schumacher P; Petzer A; Hoflehner E; Haun M; Wolf AM; Nachbaur D; Gastl G
Eur J Haematol; 2009 Jul; 83(1):48-56. PubMed ID: 19226363
[TBL] [Abstract][Full Text] [Related]
11. Defective cholesterol traffic and neuronal differentiation in neural stem cells of Niemann-Pick type C disease improved by valproic acid, a histone deacetylase inhibitor.
Kim SJ; Lee BH; Lee YS; Kang KS
Biochem Biophys Res Commun; 2007 Aug; 360(3):593-9. PubMed ID: 17624314
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells.
Jeong SG; Ohn T; Kim SH; Cho GW
Neurosci Lett; 2013 Oct; 554():22-7. PubMed ID: 24021810
[TBL] [Abstract][Full Text] [Related]
13. In vivo self-renewal of c-Kit+ Sca-1+ Lin(low/-) hemopoietic stem cells.
Osawa M; Nakamura K; Nishi N; Takahasi N; Tokuomoto Y; Inoue H; Nakauchi H
J Immunol; 1996 May; 156(9):3207-14. PubMed ID: 8617942
[TBL] [Abstract][Full Text] [Related]
14. Searching for hematopoietic stem cells. II. The heterogeneity of Thy-1.1(lo)Lin(-/lo)Sca-1+ mouse hematopoietic stem cells separated by counterflow centrifugal elutriation.
Uchida N; Jerabek L; Weissman IL
Exp Hematol; 1996 Apr; 24(5):649-59. PubMed ID: 8605970
[TBL] [Abstract][Full Text] [Related]
15. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid exhibits biphasic effects on apoptotic cell death of activated lymphocytes through differential modulation of multiple signaling pathways.
Chen Q; Ouyang DY; Geng M; Xu LH; Zhang YT; Wang FP; He XH
J Immunotoxicol; 2011; 8(3):210-8. PubMed ID: 21457087
[TBL] [Abstract][Full Text] [Related]
17. The combination of valproic acid and lithium delays hematopoietic stem/progenitor cell differentiation.
Walasek MA; Bystrykh L; van den Boom V; Olthof S; Ausema A; Ritsema M; Huls G; de Haan G; van Os R
Blood; 2012 Mar; 119(13):3050-9. PubMed ID: 22327222
[TBL] [Abstract][Full Text] [Related]
18. Common and distinct features of cytokine effects on hematopoietic stem and progenitor cells revealed by dose-response surface analysis.
Audet J; Miller CL; Eaves CJ; Piret JM
Biotechnol Bioeng; 2002 Nov; 80(4):393-404. PubMed ID: 12325147
[TBL] [Abstract][Full Text] [Related]
19. Contrasting effects of P-selectin and E-selectin on the differentiation of murine hematopoietic progenitor cells.
Eto T; Winkler I; Purton LE; Lévesque JP
Exp Hematol; 2005 Feb; 33(2):232-42. PubMed ID: 15676218
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential.
Traycoff CM; Cornetta K; Yoder MC; Davidson A; Srour EF
Exp Hematol; 1996 Feb; 24(2):299-306. PubMed ID: 8641356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
